Deciphera Pharmaceuticals Stock Price - DCPH

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 56.40 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Deciphera Pharmaceuticals Inc DCPH NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  1.47 2.68% 56.40 56.50 54.18 54.98 54.93 20:00:00
Bid Price Ask Price Spread Spread % News
39.45 66.60 27.15 40.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,853 901,345 $ 55.58 $ 50,099,065 576,673 19.69 - 56.50
Last Trade Time Type Quantity Stock Price Currency
17:09:15 formt 15,840 $ 56.40 USD

Deciphera Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.88B 51.04M $ -99.85M -2.83 - 50.92M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 13.00 0.30%

more financials information »

Deciphera Pharmaceuticals News

Date Time Source News Article
12/06/201916:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/06/201916:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
12/05/201916:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/04/201916:14Edgar (US Regulatory)Current Report Filing (8-k)
12/04/201916:05Business WireDeciphera Pharmaceuticals Announces Appointment of Ron..
11/26/201916:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/26/201916:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)

Latest DCPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DCPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week47.2556.5047.2552.61486,0559.1519.37%
1 Month48.4956.5045.8649.35457,3087.9116.31%
3 Months36.5656.5031.3742.01468,47319.8454.27%
6 Months21.9156.5019.8836.09585,80434.49157.42%
1 Year27.9456.5019.6933.15396,62528.46101.86%
3 Years20.0556.5015.1530.71308,29436.35181.3%
5 Years20.0556.5015.1530.71308,29436.35181.3%

Deciphera Pharmaceuticals Description

Deciphera Pharmaceuticals Inc is a biotechnology company, develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib.
Your Recent History
Deciphera ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191211 01:33:52